BlueRock Therapeutics società ha sostenuto
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
leggi di più
The LTI program is quite robust.
Che cosa ti rende più felice sul posto di lavoro?
I work with a very talented group of people who I love learning from.
Quali sono alcune delle cose migliori della tuo team?
Everyone on my team genuinely cares about each other and is very supportive, whether it be personal or work related.
Cosa ti piace di più del team di leadership?
The leaders at BlueRock are authentic in the way they talk about their work and in their delivery of that work.
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
We are working on challenging things with a group of people who are passionate and excited to make a difference in patients lives.
Other Employee Reviews for BlueRock Therapeutics
×